EKF Diagnostics (LON:EKF) Trading 27.3% Higher - Still a Buy?

EKF Diagnostics Holdings plc (LON:EKF - Get Free Report)'s stock price shot up 27.3% during mid-day trading on Thursday . The company traded as high as GBX 26.90 ($0.36) and last traded at GBX 25.20 ($0.33). 2,253,335 shares were traded during mid-day trading, an increase of 353% from the average session volume of 497,132 shares. The stock had previously closed at GBX 19.80 ($0.26).

EKF Diagnostics Stock Performance

The stock has a market capitalization of £114.67 million, a PE ratio of 24.01 and a beta of 0.57. The stock has a fifty day moving average of GBX 21.33 and a 200-day moving average of GBX 23.89. The company has a quick ratio of 1.77, a current ratio of 4.60 and a debt-to-equity ratio of 0.34.

EKF Diagnostics (LON:EKF - Get Free Report) last released its earnings results on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) earnings per share (EPS) for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. Equities analysts anticipate that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, insider Gavin T. Jones purchased 50,000 shares of the company's stock in a transaction that occurred on Tuesday, March 25th. The shares were purchased at an average price of GBX 22 ($0.29) per share, for a total transaction of £11,000 ($14,612.11). 5.24% of the stock is owned by company insiders.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.